Moreover, the assessment of pre-treatment CD8+ TIL density was also confirmed as a valuable predictor of distant metastasis after definitive treatment in patients with stage III/IV in hypopharyngeal HNSCC. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.